Send us Feedback

Medivation (MDVN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

MDVN » Topics » Item 2.02. Results of Operations and Financial Condition.

This excerpt taken from the MDVN 8-K filed Aug 5, 2009.

Item 2.02. Results of Operations and Financial Condition.

On August 5, 2009, Medivation, Inc. (the “Company”) announced its financial results for the second quarter ended June 30, 2009. A copy of the Company’s press release, entitled “Medivation Reports Second Quarter 2009 Financial Results and Provides Corporate Update,” is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing.

"Item 2.02. Results of Operations and Financial Condition." elsewhere:

Acorda Therapeutics (ACOR)
Affymetrix (AFFX)
Alnylam Pharmaceuticals (ALNY)
Amylin Pharmaceuticals (AMLN)
BioMarin Pharmaceutical (BMRN)
Cerus (CERS)
Dendreon (DNDN)
Dyax (DYAX)
Emergent Biosolutions (EBS)
Enzon Pharmaceuticals (ENZN)
Exelixis (EXEL)
Halozyme Therapeutics (HALO)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
ImmunoGen (IMGN)
Incyte (INCY)
Martek Biosciences (MATK)
Medarex (MEDX)
NGEN, INC. (NGEN)
NPS Pharmaceuticals (NPSP)
ARCA biopharma, Inc. (NUVO)
Omrix Biopharmaceuticals (OMRI)
Optimer Pharmaceuticals (OPTR)
Repligen (RGEN)
Seattle Genetics (SGEN)
Sequenom (SQNM)
Tercica (TRCA)
Targacept (TRGT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki